All reports

KCE Reports 396C (2025)ATMPs (Advanced Therapy Medicinal Products) are complex drugs based on cells, genes or tissues. Currently, they are mainly developed and used to treat certain cancers or genetic disorders. Only a small number of ATMPs are currently commercialised by the industry and they are often very expensive, up to several million euros per treatment.

KCE Reports 297C (2018) 3D printing is generating increased interest in the medical sector, namely in orthopaedics and dentistry, but there is no evidence that 3D-printed implants are as effective or safe as “classical” products. Yet they can currently be used without restrictions by doctors, even when they are “at high risk” (that is, more often than not, implantable).